Back
Ingles Markets 10K Form
Sell
21
IMKTA
Ingles Markets
Last Price:
65.68
Seasonality Move:
6.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | IMKTA/Ingles Markets Quarterly |
2024-02-08 | 10Q | IMKTA/Ingles Markets Quarterly |
2023-08-03 | 10Q | IMKTA/Ingles Markets Quarterly |
2023-05-04 | 10Q | IMKTA/Ingles Markets Quarterly |
2023-02-02 | 10Q | IMKTA/Ingles Markets Quarterly |
2022-08-04 | 10Q | IMKTA/Ingles Markets Quarterly |
Receive IMKTA News And Ratings
See the #1 stock for the next 7 days that we like better than IMKTA
IMKTA Financial Statistics
Sales & Book Value
Annual Sales: | $5.89B |
---|---|
Cash Flow: | $58.61M |
Price / Cash Flow: | 12.46 |
Annual Sales: | $81.80 |
Price / Book: | 0.8 |
Profitability
EPS (TTM): | 8.40000 |
---|---|
Net Income (TTM): | $159.66M |
Gross Margin: | $1.4B |
Return on Equity: | 10.73% |
Return on Assets: | 6.45% |
Ingles Markets Earnings Forecast
Key Ingles Markets Financial Ratios
- The Gross Profit Margin over the past 38 years for IMKTA is 23.84%.
- The Selling, General & Administrative Expenses for IMKTA have been equal to 18.93% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 10.47% of Operating Income.
- The Net Earning history of IMKTA is 3.58% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 22 years.
Ingles Markets Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Consumer Staples Distribution & Retail |
Sector: | Consumer Staples |
Current Symbol: | IMKTA |
CUSIP: | 457030 |
Website: | ingles-markets.com |
Debt
Debt-to-Equity Ratio: | 0.34 |
---|---|
Current Ratio: | 2.99 |
Quick Ratio: | 1.41 |
Price-to-Earnings
Trailing P/E Ratio: | 5.86 |
---|---|
Forward P/E Ratio: | 0 |
IMKTA Technical Analysis vs Fundamental Analysis
Sell
21
Ingles Markets (IMKTA)
is a Sell
Is Ingles Markets a Buy or a Sell?
-
Ingles Markets stock is rated a Sell
The current Ingles Markets [IMKTA] share price is $65.05. The Score for IMKTA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.